A number of firms have modified their ratings and price targets on shares of Astera Labs (NASDAQ: ALAB) recently:
- 8/5/2026 – Astera Labs had its price target lowered by TD Cowen from $425.00 to $375.00. They now have a “hold” rating on the stock.
- 8/5/2026 – Astera Labs had its “buy” rating reaffirmed by Roth Capital. They now have a $450.00 price target on the stock.
- 8/5/2026 – Astera Labs had its price target raised by Royal Bank Of Canada from $425.00 to $500.00. They now have an “outperform” rating on the stock.
- 8/5/2026 – Astera Labs had its “neutral” rating reaffirmed by UBS Group AG. They now have a $425.00 price target on the stock.
- 8/5/2026 – Astera Labs had its price target raised by Jefferies Financial Group Inc. from $270.00 to $450.00. They now have a “buy” rating on the stock.
- 8/5/2026 – Astera Labs had its price target raised by Needham & Company LLC from $260.00 to $425.00. They now have a “buy” rating on the stock.
- 8/3/2026 – Astera Labs had its price target raised by Morgan Stanley to $335.00. They now have an “overweight” rating on the stock.
- 7/31/2026 – Astera Labs had its price target raised by Susquehanna from $230.00 to $275.00. They now have a “neutral” rating on the stock.
- 7/29/2026 – Astera Labs had its “buy” rating reaffirmed by Citigroup Inc..
- 7/20/2026 – Astera Labs had its price target raised by Barclays PLC from $200.00 to $325.00. They now have an “equal weight” rating on the stock.
- 7/13/2026 – Astera Labs had its price target raised by TD Cowen from $225.00 to $425.00. They now have a “hold” rating on the stock.
- 6/29/2026 – Astera Labs had its price target raised by UBS Group AG from $205.00 to $400.00. They now have a “neutral” rating on the stock.
- 6/24/2026 – Astera Labs had its price target raised by Stifel Nicolaus from $260.00 to $460.00. They now have a “buy” rating on the stock.
- 6/23/2026 – Astera Labs had its price target raised by Bank of America Corporation from $240.00 to $450.00. They now have a “neutral” rating on the stock.
Insider Activity at Astera Labs
In other news, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of Astera Labs stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the sale, the director owned 57,466 shares of the company’s stock, valued at $25,859,700. This trade represents a 5.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,244,395 shares of company stock valued at $358,865,571. 10.40% of the stock is currently owned by insiders.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Astera Labs Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs Inc and related companies with MarketBeat.com's FREE daily email newsletter.
